4//SEC Filing
Anand Bhaskar 4
Accession 0001890784-25-000005
CIK 0001599298other
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 4:11 PM ET
Size
5.3 KB
Accession
0001890784-25-000005
Insider Transaction Report
Form 4
Anand Bhaskar
Chief Accounting Officer
Transactions
- Award
Common Stock
2025-10-21$18.74/sh+26,680$499,983→ 159,751 total
Footnotes (2)
- [F1]Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025.
- [F2]Holdings include shares previously acquired through exempt transactions pursuant to the Issuer's employee stock purchase plan.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001890784
Filing Metadata
- Form type
- 4
- Filed
- Oct 22, 8:00 PM ET
- Accepted
- Oct 23, 4:11 PM ET
- Size
- 5.3 KB